Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

NCT02484573 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhoses

Interventions

DRUG: Propanolol

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran